Crispr Therapeutics Ag (CRSP)

Hedge Fund Holdings
Filing Period:
Last update:
No. Hedge Fund Shares Value (x$1000) Activity % Port
1.
ARK Investment Management

Catherine D. Wood

8,290,350 $1,010,179 -21% 2%
2.
Two Sigma Advisors

John Overdeck And David Siegel

1,027,700 $125,225 +186% 0.34%
3.
OrbiMed Advisors

Samuel Isaly

552,500 $67,322 +23% 0.62%
4. 364,700 $44,439 +59% 0.01%
5. 349,700 $42,611 +24% 0.01%
Insider Trading: Purchases See All
Insider Price Amount Relationship Remaining Holdings Date Form 4
$24.95 27,461 Large Shareholder 5,380,940 2018-12-27 Filing
$24.89 12,737 Large Shareholder 5,353,479 2018-12-26 Filing
$24.97 53,655 Large Shareholder 5,340,742 2018-12-24 Filing
$23.18 11,742 Large Shareholder 5,287,087 2018-12-24 Filing
$22.91 2,603 Large Shareholder 5,275,345 2018-12-24 Filing
Insider Trading: Sales See All
Insider Price Amount Relationship Remaining Holdings Date Form 4
$127.51 3,488 Officer, Director 187,719 2021-06-15 Filing
$126.86 16,129 Officer, Director 191,207 2021-06-15 Filing
$125.39 10,383 Officer, Director 207,336 2021-06-15 Filing
$129.45 755 Director 20,375 2021-06-11 Filing
$128.65 1,100 Director 21,130 2021-06-11 Filing
Institutional Investors' Holdings
Filing Period:
No. Name Shares Value (x$1000) % Port
1. 141,054 $17,187,429 0%
2. 85,800 $10,454,730 0.11%
3. 24,000 $2,924,400 0.03%
4. 20,903 $2,547,030 0.02%
5. 5,981 $729,000 0%
News See All